Welcome to MIHMEP. More than a Master’s degree, more than an MBA specialized in healthcare.
MIHMEP is a 360 degree experience that prepares participants to become effective leaders, managers, policy-makers, economists, and change agents. We cover the healthcare sector and organizations of developed countries, the global health context of developing countries, and the pharmaceutical, medical device, and all other types of industries related to health and wellbeing. The MIHMEP is something unique.
We have a faculty of 50 full-time professors at SDA Bocconi School of Management, and more than 30 top-level visiting professors and guest speakers, many of them policy-makers and practitioners with roles ranging from “board to ward” in health organizations, or from “CEO to shop floor” in the industry. The faculty members of SDA Bocconi also regularly teach in short-, long- and master-level executive programs, providing the MIHMEP class the value-added combination of rigorous theory with first-hand experience of real-life dynamics of health organizations, systems, and industries.
The Master is directly linked to a knowledge tank, the Bocconi CERGAS (Centre for Research on Health and Social Care Management), where they carry out investigations and action-research on state-of-the-art innovations and changes taking place in health sectors and systems all over the world. Knowledge is continuously transferred from the center to the MIHMEP class, guaranteeing that topics, case studies, exercises, and roleplay are always updated.
In addition to all this, we also have a strong network with many kinds of working environments, as SDA Bocconi runs customized training and research programs that cultivate relationships with health organizations, authorities, institutions, systems, and international organizations and industries year after year. Plus, MIHMEP has over 400 alumni all over the world, the ambassadors of their beloved program. No surprise that opportunities for internships and jobs flourish in this context. And every year we have a truly international class, with more than 15 countries represented. No other master in healthcare can boast this environment.
Are you ready for a challenging journey where technical knowledge is only a part of the picture? Do you really want to grow into a 360 degree leader in your field? Do you want to broaden your professional horizons and become a forward thinker, able to understand and decode the increasing complexity of the current healthcare environment?
And, are you ready to spend 9 months of your life in Italy and in Milan, one of the most cosmopolitan and culture-rich cities in the world? In a country that runs one of the world’s best national health systems, is among the top five markets for industries, and operates the largest part of the agencies and organizations that support the health systems of developing countries. Where three medical schools – in Padova, Bologna, and Salerno – date back to the Middle Ages. Where mental health patients were de-institutionalized for the first time worldwide in the late 1970s, thus carving a path for other health systems.
If healthcare is what you’re interest in, the place to be is MIHMEP. You can count on my total commitment to further the reputation and leadership that MIHMEP has developed over the last 20 years, by following in the footsteps of my predecessor and by nurturing the community of MIHMEP alumni and the relationships with the working environment.
I look forward to welcoming you to Milan and to SDA Bocconi School of Management.
Claudio Jommi | MIHMEP Director 2019-2020
Claudio Jommi is Professor of Practice at SDA Bocconi School of Management (Government, Health and Not for Profit Division). He is also Member of the Executive Committee, Director of the Health Policy Area and Scientific Coordinator of the Pharmaceutical Observatory at Cergas (Centre for Research on Health and Social Care Management), SDA Bocconi.
He is Director of the Master in International Health Management Economics and Policy (Mihmep), 2019-2020 Edition at SDA Bocconi. He is currently Coordinator of the Specialisation of Pharmaceuticals and Medical Technologies at Mihmep where he also teaches Health Economics and Pharmaceutical Policy and Management. He holds many Executive Courses on Health Technology Assessment and Market Access.
He was Associate Professor of Management at the Department of Pharmaceutical Sciences, University of Novara, where he (i) was member of the University Patent Committee, (ii) taught different undergraduate courses (Management of Pharmacy and Pharmacoeconomics; Intellectual Property Rights and Technology Transfer; Economics and Management of Pharmaceuticals) and (iii) was member of the Scientific Board of the Master in Regulatory Affairs and Market Access.
He has been a visiting professor at Essec Business School, Cergy (Paris), at the Herivan K. Haub School of Business, St Joseph University, Philadelphia (US), at the Andrija School of Public Health, Zagreb and the University of Claude Bernard Lyon 1 (European Market Access University Diploma) (Paris).
He was the President of the Italian Health Economics Association (2014-2017).
His research activity is focused on Market Access for Medicines and other Medical Technologies, Pharmaceutical Economics, Policy and Management, Health Technology Assessment and Decision Making in Health Care.
He has had his work published in many international and national journals, including Drug Design Development and Therapy, Frontiers in Pharmacology, European Journal of Health Economics, Health Policy, International Journal of Health Planning and Management, Journal of Medical Marketing, Pharmacoeconomics, PLOS and PLOS Neglected Diseases, Public Money and Management, Social Science and Medicine, Value in Health.
He is also the Editor in Chief of the Journal Global and Regional Health Technology Assessment.
He is Member of ISPOR (International Society for Pharmacoeconomics and Outcome Research); he was member of the National Committee by the Consiglio Superiore di Sanità “Economic impact of NIPT – Non-invasive prenatal test – in the Italian National Health Service” and he was Advisor of Aifa (Italian Medicines Agency) to reform the medicines price and reimbursement process. He is also Member of the Scientific Board of the Bioindustry Park, Canavese, Italy.
He systematically participate in international Conferences, such has ISPOR, iHEA (International Health Economics Association) and EUHEA (European Health Economics Association).
He joined international Advisory Boards supporting the Pharmaceutical Companies on Economic Evidence for Market Access purposes.